| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | +16.2% | +15.7% |
| Cost of Revenue | $2.7M | +15.7% | +37.3% |
| Gross Profit | $5.4M | +16.5% | +7.4% |
| R&D Expense | $1.8M | -5.4% | -3.3% |
| SG&A Expense | $5.9M | -4.3% | -12.8% |
| Operating Income | -$6.6M | +17.8% | +11.2% |
| Pre-tax Income | -$6.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | -7.8% | -23.1% |
| Accounts Receivable | $3.1M | +36.9% | +78.7% |
| Inventory | $5.5M | -2.6% | +1.7% |
| Current Assets | $64.7M | -5.7% | -25.9% |
| Total Assets | $130.9M | -4.1% | -38.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.8M | — | — |
| Capital Expenditures | $460K | — | — |
| Investing Cash Flow | $17.1M | — | — |
| Financing Cash Flow | -$70K | — | — |
| Free Cash Flow | -$17.2M | — | — |
| +16.9% |
| +8.7% |
| Income Tax | -$19K | -258.3% | +29.6% |
| Net Income | -$6.1M | +17.3% | +8.6% |
| EPS (Basic) | -$0.01 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% | +0.0% |
| $8.4M |
| +3.8% |
| +4.6% |
| Total Liabilities | $11.2M | +0.9% | -0.5% |
| Stockholders' Equity | $119.7M | -4.5% | -41.0% |